Addendum to report of the Global Advisory Committee on Vaccine Safety (GACVS), 10-11 June 2015¹. Safety of CYD-TDV dengue vaccine

scientific article published on 01 August 2015

Addendum to report of the Global Advisory Committee on Vaccine Safety (GACVS), 10-11 June 2015¹. Safety of CYD-TDV dengue vaccine is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID26298882

P433issue34
P921main subjectvaccine safetyQ105256838
P304page(s)421-423
P577publication date2015-08-01
P1433published inWeekly Epidemiological RecordQ26842229
P1476titleAddendum to report of the Global Advisory Committee on Vaccine Safety (GACVS), 10-11 June 2015¹. Safety of CYD-TDV dengue vaccine
P478volume90

Reverse relations

cites work (P2860)
Q92093930Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions
Q27928072Dengue vaccine: local decisions, global consequences
Q63246344Efficacy, immunogenicity and safety of a recombinant tetravalent dengue vaccine (CYD-TDV) in children aged 2-17 years: systematic review and meta-analysis
Q52684747Safety issues from a Phase 3 clinical trial of a live-attenuated chimeric yellow fever tetravalent dengue vaccine

Search more.